-
- 早坂 正敏
- Department of Pharmacy, Nihon University Itabashi Hospital
-
- 藏内 恭子
- Department of Pharmacy, Surugadai Nihon University Hospital
-
- 葉山 達也
- Department of Pharmacy, Nihon University Itabashi Hospital
-
- 吉田 善一
- Department of Pharmacy, Nihon University Itabashi Hospital
-
- 丹正 勝久
- Department of Pharmacy, Nihon University Itabashi Hospital Department of Emergency and Critical Care Medicine, Nihon University of Medicine
書誌事項
- タイトル別名
-
- The Necessity of 24-hour Participation by a Pharmacist in Initial Treatment at the Emergency and Critical Care Center
この論文をさがす
抄録
At the Emergency and Critical Care Center, a pharmacist has been required to participate in initial treatment for 24 hours a day. And this study was performed to evaluate the necessity. Patients taken to the centre between August 1, 2009 and December 31, 2009 were classified into 3 groups according to the time they arrived (from 9:00 to 17:00 [group 9-17], from 17:00 to 1:00 [group 17-1], and from 1:00 to 9:00 [group 1-9]). The number of all patients, intoxicated patients, the rate of the number and types of used injection drugs were investigated. Also the number of cases of drug information pharmacists gave to physicians or nurses whether orally or in writing was investigated. In this study the proportion of intoxicated patients to all patients was 25 (6.7%) in group 9-17, 27 (8.4%) in group 17-1, and 28 (14.1%) in group 1-9, indicating group 1-9 was significantly higher than group 9-17. The majority (73 cases (54%)) of information supplied in the initial treatment was about intoxication. In emergency and critical care, patients are admitted at anytime. Furthermore, intoxicated patients are more likely to be admitted at nighttime. Moreover, drug information about intoxication, drug dose and effects are needed. Therefore, it is suggested that pharmacists 24-hour participation in initial treatment is necessary and pharmacists are required to participate more in emergency and critical care.
収録刊行物
-
- 医療薬学
-
医療薬学 38 (5), 313-321, 2012
一般社団法人日本医療薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204777357824
-
- NII論文ID
- 130004502739
-
- ISSN
- 18821499
- 1346342X
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可